Sunday, July 3, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Clinical determinants of post-COVID-19 thromboembolism

by Medical Finance
in Coronavirus
Study: Venous Thromboembolism in Ambulatory Covid-19 patients: Clinical and Genetic Determinants. Image Credit: Kateryna Kon / Shutterstock.com
9
SHARES
103
VIEWS
Share on FacebookShare on Twitter

Various case and hospital-based studies have shown a high risk of venous thromboembolism (VTE) in patients with severe coronavirus disease 2019 (COVID-19). More specifically, a pooled VTE rate of 14.7% and 23.2% was reported in a recent meta-analysis among patients who were admitted to the hospital and intensive care units (ICUs), respectively.

Study: Venous Thromboembolism in Ambulatory Covid-19 patients: Clinical and Genetic Determinants. Image Credit: Kateryna Kon / Shutterstock.com

Study: Venous Thromboembolism in Ambulatory Covid-19 patients: Clinical and Genetic Determinants. Image Credit: Kateryna Kon / Shutterstock.com

Background

Several randomized controlled trials have also demonstrated the benefit-risk of anticoagulation therapy for COVID-19 patients who were at different stages of the disease. Despite these findings, there remains a lack of recommended interventions for the prevention of VTE amongst ambulatory patients with COVID-19.

The global rollout of vaccines, the widespread transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant, and the relaxation of public health restrictions have caused an increase in the number of milder COVID-19 cases that are managed in ambulatory settings. Simultaneously, the lack of insight regarding the impact of clinical, genetic, and socio-economical risk factors on infection-related VTE has persisted.

A new study published on the preprint server medRxiv* aims to quantify the risk of acute VTE due to SARS-CoV-2 infection in ambulatory settings, as well as identify the clinical and genetic risks of VTE determinants following SARS-CoV-2 infection.

About the study

The current study included U.K. Biobank (UKBB) participants from England who were alive on March 1, 2020. Study participants were divided into an infected cohort and a non-infected cohort.

Participants who tested positive for COVID-19 by polymerase-chain-reaction (PCR) assay between March 1, 2020, and September 30, 2021, were included in the infected cohort, while participants who never tested or only had negative test results were included in the non-infected cohort.

Cumulative incidence curves of venous thromboembolic events within 30 days.

Cumulative incidence curves of venous thromboembolic events within 30 days.

Thereafter, an index date was defined as the date of the first positive specimen sample for the infected cohort and a random date during the same period for the matched non-infected cohort. Participants who used antithrombotic drugs one year before index dates with historical VTE, as well as those who tested positive in hospital settings, were excluded from the study.

Inherited thrombophilia carriers were defined as those with two risk single nucleotide polymorphisms (SNPs) in Factor V Leiden or Prothrombin G20210A. A 297-SNPs polygenic risk score (PRS) was also calculated for VTE that did not include these two variants.

A list of co-variates was studied such as demographics, body mass index (BMI), socio-economic status, comorbidities, vaccination status, number of hospitalizations in the last one year, and medications taken before one year of the index date. Participants were followed up for 30 days after the index date for the occurrence of incident VTE comprising either deep vein thrombosis or pulmonary embolism.

Study findings

Out of the 407,311 UKBB participants, 26,210 were infected with SARS-CoV-2 during the study period. After applying the exclusion criteria, 83% of infected participants and 78.23% of non-infected participants were included in the study. Of the infected participants, 13% were tested in hospitals, and 87% were tested in outpatient settings.

Ambulatory COVID-19 patients were found to be younger than the uninfected, from non-White ethnicity, and more likely to be male, obese, and more socioeconomically deprived. A total of 73 and 17 VTE events were observed among ambulatory patients and matched uninfected within the 30 days follow-up period, respectively. Furthermore, SARS-CoV-2 infection was associated with an increased risk of VTE, especially in unvaccinated participants.

Men, older participants, and people who were obese were at a higher risk of COVID-19-associated VTE, while a two-dose vaccination was associated with a lower risk of COVID-19-related VTE.

Out of all the infected participants, 1,287 had inherited thrombophilia with 392 carrying the risk variant of Prothrombin G20210A and 909 carrying the risk variant of Factor V Leiden. Participants with inherited thrombophilia were at a higher risk of VTE following SARS-CoV-2 infection as compared to those without. However, no association was found between inherited thrombophilia and arterial thromboembolism.

Conclusions

The current study demonstrates that ambulatory COVID-19 was associated with a 20-fold increase in incident VTE; however, no elevated risk was observed in fully vaccinated individuals. Several factors such as sex, older age, and obesity could increase the risk of COVID-19 related VTE.

Additionally, inherited thrombophilia was found to double the risk of COVID-19 related VTE. Therefore, high vaccine coverage and targeted strategies are required to prevent VTE during the outpatient care of COVID-19.

Limitations

The current study was not free from residual confounding. Additional limitations included that the study population could not fully represent the general population and that the association of asymptomatic infection with VTE risk was not assessed. Finally, the estimates of the study were an average and mixed effect of several SARS-CoV-2 strains.

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: BNT162b2 Protection against the Omicron Variant in Children and Adolescents. Image Credit: Dkoi / Shutterstock

How well does the BNT162b2 vaccine protect children and teens against Omicron?

by Medical Finance
July 3, 2022
0

A recent study published in the New England Journal of Medicine investigated the vaccine efficiency of the Pfizer BioNTech (BNT162b2)...

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

by Medical Finance
July 3, 2022
0

In a recent study published in the journal Science, researchers observed differential effector functions of antibodies elicited by Pfizer’s BNT162b2...

Study: Effect of Early Treatment with Ivermectin among Patients with Covid-19. Image Credit: NIAID

COVID-19 study proves ivermectin ineffective

by Medical Finance
July 3, 2022
0

A recent study published in the New England Journal of Medicine investigated the impact of ivermectin, an antiparasitic drug, as...

Study: RNA editing increases the nucleotide diversity of SARS-CoV-2 in human host cells. Image Creditr: Orpheus FX / Shutterstock

Evidence SARS-CoV-2 undergoes ADAR-mediated A-to-I RNA editing in human cells

by Medical Finance
July 3, 2022
0

In a recent study published in the journal PLOS Genetics, researchers explored severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) ribonucleic acid...

Study: Bats host the most virulent—but not the most dangerous—zoonotic viruses. Image Credit: shutter_o / Shutterstock.com

Bats carry some of the most virulent, but not the most dangerous zoonotic viruses

by Medical Finance
July 3, 2022
0

The current coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered a...

Study: Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative. Image Credit: angellodeco / Shutterstock.com

TLR7 and MARK1 genomic variants impact COVID-19 prognosis

by Medical Finance
July 3, 2022
0

As of April 3, 2022, coronavirus disease 2019 (COVID-19) has caused almost 6.2 million deaths worldwide. While in many developed...

Next Post
Study: High neutrophils and triglycerides lead to critical illness in 2 COVID-19 and reveal CDK6 inhibitors as potential treatment. Image Credit: StudioMolekuul / Shutterstock.com

a potential drug target for severe COVID-19

Study: Early detection of SARS-CoV-2 variants using traveler-based genomic surveillance at four US airports. Image Credit: Thanakorn.P / Shutterstock.com

U.S. traveler-based genomic surveillance provided early SARS-CoV-2 variant detection

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • detail of microscope lenses observing a slide with sample wells in the laboratory angellodeco e84c7a54b30247a0a1ad679809f0b548 620x480
    Researchers combine two emerging imaging technologies to better view biomolecules
  • bacteria Sebastian Kaulitzki 46826fb7971649bfaca04a9b4cef3309 620x480
    OSU researchers study quorum sensing in a gram-negative bacterium that displays social behaviors
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply